GGrantIndex
← Leaderboards

Angion Biomedica Corporation

Garden City, NY

Compare ↔
$63,583,068
Total funding
71
Grants

Funding over time

peak $11.4M · FY2005–19
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$63,583,068 · 71

By mechanism

R44$52,070,776 · 24
R43$11,512,292 · 47

Investigators at Angion Biomedica Corporation

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Quaisar Ali$220,7311 gr2Michael A Yamin$219,5461 gr

All-Time

Most funded here, all years

1Prakash Narayan$20,015,26821 gr2Weizhong Cai$17,018,17112 gr3David E Smith$8,398,0757 gr4Latha Paka$8,163,08910 gr5Bert J. W. M. Oehlen$7,885,44212 gr6Peter F Mento$1,031,8277 gr7Youzhi Tong$426,9462 gr8Quaisar Ali$220,7311 gr

Largest grants

Renal Injury Prevention by SF/HGF-like Small Molecules$1,831,724
R44 · FY2003 · DK
Anti-Fibrotic Therapy for Scleroderma/SSc$1,584,102
R44 · FY2014 · AR
Safety and PK Study in Hepatic Impairment Patients$1,553,079
R44 · FY2010 · AA
A Pilot Clinical Study in Acute STEMI$1,484,711
R44 · FY2011 · HL
A Pilot Clinical Study in Acute STEMI$1,430,128
R44 · FY2010 · HL
Safety and PK Study in Hepatic Impairment Patients$1,426,068
R44 · FY2009 · AA
Treatment for alcoholic liver disease$1,223,250
R44 · FY2012 · AA
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke$1,194,283
R44 · FY2012 · NS
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke$1,173,372
R44 · FY2010 · NS
Therapeutic use of small-molecule HGF-mimetic for emphysema$1,135,445
R44 · FY2009 · HL
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke$1,123,879
R44 · FY2009 · NS
Kidney Preservation for Transplantation$1,121,256
R44 · FY2007 · DK
Refanalin for lung preservation and transplantation$1,117,921
R44 · FY2009 · HL
Novel Neuroprotective/Anti-inflammatory Therapy for Ischemic Stroke$1,104,634
R44 · FY2009 · NS
Small Molecule Therapeutics for Renal Disease$1,094,052
R44 · FY2010 · DK
Novel Small Molecules For Acute Liver Failure$1,079,261
R44 · FY2008 · AA
Novel Neuroprotective/Anti-inflammatory Therapy for Ischemic Stroke$1,071,937
R44 · FY2010 · NS
Hepatic Growth Factor Mimetic for Liver Fibrosis$1,063,817
R44 · FY2005 · AA
SF/HGF Gene Transfer for Peripheral Ischemia$1,059,850
R44 · FY2002 · HL
A Novel Therapeutic for Liver Fibrosis$1,038,130
R44 · FY2013 · AA